{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:57:39Z","timestamp":1792519059125,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"DOI":"10.1186\/s13014-025-02747-z","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:58:44Z","timestamp":1763006324000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Re-irradiation in oligorecurrence and oligometastatic cervical cancer in modern radiotherapy era"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0334-2551","authenticated-orcid":false,"given":"Wiwatchai","family":"Sittiwong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6957-8861","authenticated-orcid":false,"given":"Tissana","family":"Prasartseree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9353-5410","authenticated-orcid":false,"given":"Pongpop","family":"Tuntapakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8115-9077","authenticated-orcid":false,"given":"Wajana","family":"Thaweerat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1211-2275","authenticated-orcid":false,"given":"Nantakan","family":"Apiwarodom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7026-3955","authenticated-orcid":false,"given":"Yaowalak","family":"Chansilpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1150-1399","authenticated-orcid":false,"given":"Pittaya","family":"Dankulchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"issue":"3","key":"2747_CR1","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.3892\/ol.2020.11754","volume":"20","author":"R Hull","year":"2020","unstructured":"Hull R, Mbele M, Makhafola T, Hicks C, Wang SM, Reis RM, et al. Cervical cancer in low and middle-income countries. Oncol Lett. 2020;20(3):2058\u201374.","journal-title":"Oncol Lett"},{"issue":"1","key":"2747_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13027-023-00562-3","volume":"19","author":"ER Allanson","year":"2024","unstructured":"Allanson ER, Zafar SN, Anakwenze CP, Schmeler KM, Trimble EL, Grover S. The global burden of cervical cancer requiring surgery: database estimates. Infect Agent Cancer. 2024;19(1):5.","journal-title":"Infect Agent Cancer"},{"issue":"1","key":"2747_CR3","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s12905-022-02043-y","volume":"22","author":"Z Petersen","year":"2022","unstructured":"Petersen Z, Jaca A, Ginindza TG, Maseko G, Takatshana S, Ndlovu P, et al. Barriers to uptake of cervical cancer screening services in low-and-middle-income countries: a systematic review. BMC Womens Health. 2022;22(1):486.","journal-title":"BMC Womens Health"},{"issue":"4","key":"2747_CR4","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.ijrobp.2019.03.038","volume":"104","author":"LT Tan","year":"2019","unstructured":"Tan LT, Potter R, Sturdza A, Fokdal L, Haie-Meder C, Schmid M, et al. Change in patterns of failure after Image-Guided brachytherapy for cervical cancer: analysis from the retroembrace study. Int J Radiat Oncol Biol Phys. 2019;104(4):895\u2013902.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2747_CR5","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.radonc.2011.07.012","volume":"100","author":"R Potter","year":"2011","unstructured":"Potter R, Georg P, Dimopoulos JC, Grimm M, Berger D, Nesvacil N, et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol. 2011;100(1):116\u201323.","journal-title":"Radiother Oncol"},{"issue":"1","key":"2747_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","volume":"13","author":"S Hellman","year":"1995","unstructured":"Hellman S, Weichselbaum RR, Oligometastases. J Clin Oncol. 1995;13(1):8\u201310.","journal-title":"J Clin Oncol"},{"issue":"11","key":"2747_CR7","doi-asserted-by":"publisher","first-page":"8491","DOI":"10.18632\/oncotarget.3455","volume":"6","author":"DK Reyes","year":"2015","unstructured":"Reyes DK, Pienta KJ. The biology and treatment of oligometastatic cancer. Oncotarget. 2015;6(11):8491\u2013524.","journal-title":"Oncotarget"},{"key":"2747_CR8","doi-asserted-by":"publisher","first-page":"261096","DOI":"10.1155\/2012\/261096","volume":"2012","author":"Y Niibe","year":"2012","unstructured":"Niibe Y, Chang JY. Novel insights of oligometastases and oligo-recurrence and review of the literature. Pulm Med. 2012;2012:261096.","journal-title":"Pulm Med"},{"key":"2747_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.radonc.2020.04.003","volume":"148","author":"Y Lievens","year":"2020","unstructured":"Lievens Y, Guckenberger M, Gomez D, Hoyer M, Iyengar P, Kindts I, et al. Defining oligometastatic disease from a radiation oncology perspective: an ESTRO-ASTRO consensus document. Radiother Oncol. 2020;148:157\u201366.","journal-title":"Radiother Oncol"},{"issue":"4","key":"2747_CR10","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.ijrobp.2022.07.002","volume":"114","author":"S Chopra","year":"2022","unstructured":"Chopra S, Kalra B, Mulani J, Jain J, Gurram L, Mittal P, et al. Salvage (Re)radiation in oligometastatic and oligorecurrent cervical cancer. Int J Radiat Oncol Biol Phys. 2022;114(4):812\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2747_CR11","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ygyno.2017.10.017","volume":"148","author":"MS Ning","year":"2018","unstructured":"Ning MS, Ahobila V, Jhingran A, Stecklein SR, Frumovitz M, Schmeler KM, et al. Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer. Gynecol Oncol. 2018;148(1):132\u20138.","journal-title":"Gynecol Oncol"},{"key":"2747_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ygyno.2023.10.016","volume":"179","author":"P Critelli","year":"2023","unstructured":"Critelli P, Pezzulla D, Lillo S, Arpa D, Scricciolo M, Di Carlo C, et al. Outcomes and toxicity in re-irradiation of gynecologic cancer: systematic review of the Italian association of radiation and clinical oncology (AIRO). Gynecol Oncol. 2023;179:33\u201341.","journal-title":"Gynecol Oncol"},{"key":"2747_CR13","doi-asserted-by":"publisher","first-page":"943703","DOI":"10.3389\/fonc.2022.943703","volume":"12","author":"X Ren","year":"2022","unstructured":"Ren X, Fu Y, Liu Z, Lin X, Qiu L, Li Y, et al. Image-guided interstitial brachytherapy for recurrent cervical cancer after radiotherapy: A single institution experience. Front Oncol. 2022;12:943703.","journal-title":"Front Oncol"},{"key":"2747_CR14","doi-asserted-by":"crossref","unstructured":"Bockel S, Espenel S, Sun R, Dumas I, Gouy S, Morice P et al. Image-Guided brachytherapy for salvage reirradiation: A systematic review. Cancers (Basel). 2021;13(6).","DOI":"10.3390\/cancers13061226"},{"issue":"1","key":"2747_CR15","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1186\/s12885-023-11406-z","volume":"23","author":"M Shan","year":"2023","unstructured":"Shan M, Deng Y, Zou W, Fan S, Li Y, Liu X, et al. Salvage radiotherapy strategy and its prognostic significance for patients with locoregional recurrent cervical cancer after radical hysterectomy: a multicenter retrospective 10-year analysis. BMC Cancer. 2023;23(1):905.","journal-title":"BMC Cancer"},{"issue":"3","key":"2747_CR16","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.ygyno.2021.12.022","volume":"164","author":"KL Corrigan","year":"2022","unstructured":"Corrigan KL, Yoder A, De B, Lin L, Jhingran A, Joyner MM, et al. Long-term survival following definitive radiation therapy for recurrence or oligometastases in gynecological malignancies: A landmark analysis. Gynecol Oncol. 2022;164(3):550\u20137.","journal-title":"Gynecol Oncol"},{"key":"2747_CR17","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ygyno.2024.10.023","volume":"191","author":"KS Hunsberger","year":"2024","unstructured":"Hunsberger KS, Tewari KS, Monk BJ, Chase DM. Standard of care treatment for stage IVB cervical cancer: A systematic review and meta-analysis. Gynecol Oncol. 2024;191:259\u201364.","journal-title":"Gynecol Oncol"},{"issue":"25","key":"2747_CR18","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1200\/JCO.20.00818","volume":"38","author":"DA Palma","year":"2020","unstructured":"Palma DA, Olson R, Harrow S, Gaede S, Louie AV, Haasbeek C, et al. Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: Long-Term results of the SABR-COMET phase II randomized trial. J Clin Oncol. 2020;38(25):2830\u20138.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2747_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13014-023-02320-6","volume":"18","author":"J Li","year":"2023","unstructured":"Li J, Wang Y, Huo L, Huang X, Shi L, Huang L, et al. Definitive irradiation as a first treatment strategy for primary and metastatic sites of newly diagnosed IVB cervical cancer that presented with synchronous oligometastases. Radiat Oncol. 2023;18(1):159.","journal-title":"Radiat Oncol"},{"issue":"1","key":"2747_CR20","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.3802\/jgo.2020.31.e8","volume":"31","author":"H Li","year":"2020","unstructured":"Li H, Pang Y, Cheng X. Surgery of primary sites for stage IVB cervical cancer patients receiving chemoradiotherapy: a population-based study. J Gynecol Oncol. 2020;31(1):e8.","journal-title":"J Gynecol Oncol"},{"key":"2747_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.radonc.2020.10.037","volume":"155","author":"S Chopra","year":"2021","unstructured":"Chopra S, Mangaj A, Sharma A, Tan LT, Sturdza A, Jurgenliemk-Schulz I, et al. Management of oligo-metastatic and oligo-recurrent cervical cancer: A pattern of care survey within the EMBRACE research network. Radiother Oncol. 2021;155:151\u20139.","journal-title":"Radiother Oncol"},{"key":"2747_CR22","first-page":"100690","volume":"43","author":"J Li","year":"2023","unstructured":"Li J, Huang L, Wu H, Li J, Cao X, Liu Z. Re-irradiation for recurrent cervical cancer: A single institutional experience. Clin Transl Radiat Oncol. 2023;43:100690.","journal-title":"Clin Transl Radiat Oncol"},{"issue":"9","key":"2747_CR23","first-page":"5103","volume":"35","author":"HJ Park","year":"2015","unstructured":"Park HJ, Chang AR, Seo Y, Cho CK, Jang WI, Kim MS, et al. Stereotactic body radiotherapy for recurrent or oligometastatic uterine cervix cancer: A cooperative study of the Korean radiation oncology group (KROG 14\u2009\u2013\u200911). Anticancer Res. 2015;35(9):5103\u201310.","journal-title":"Anticancer Res"},{"issue":"2","key":"2747_CR24","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.1111\/ajco.12185","volume":"12","author":"Y Seo","year":"2016","unstructured":"Seo Y, Kim MS, Yoo HJ, Jang WI, Rhu SY, Choi SC, et al. Salvage stereotactic body radiotherapy for locally recurrent uterine cervix cancer at the pelvic sidewall: feasibility and complication. Asia Pac J Clin Oncol. 2016;12(2):e280\u20138.","journal-title":"Asia Pac J Clin Oncol"},{"issue":"10","key":"2747_CR25","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.clon.2023.07.011","volume":"35","author":"G Macchia","year":"2023","unstructured":"Macchia G, Pezzulla D, Cilla S, Buwenge M, Romano C, Ferro M, et al. Stereotactic body reirradiation in gynaecological cancer: outcomes and toxicities from a single institution experience. Clin Oncol (R Coll Radiol). 2023;35(10):682\u201393.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"14","key":"2747_CR26","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1002\/cncr.30058","volume":"122","author":"AC Wong","year":"2016","unstructured":"Wong AC, Watson SP, Pitroda SP, Son CH, Das LC, Stack ME, et al. Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT). Cancer. 2016;122(14):2242\u201350.","journal-title":"Cancer"},{"issue":"12","key":"2747_CR27","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","volume":"17","author":"DR Gomez","year":"2016","unstructured":"Gomez DR, Blumenschein GR Jr., Lee JJ, Hernandez M, Ye R, Camidge DR, et al. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol. 2016;17(12):1672\u201382.","journal-title":"Lancet Oncol"}],"updated-by":[{"DOI":"10.1186\/s13014-026-02832-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000}}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02747-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-025-02747-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02747-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:36:23Z","timestamp":1781328983000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13014-025-02747-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2747"],"URL":"https:\/\/doi.org\/10.1186\/s13014-025-02747-z","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13014-026-02832-x","URL":"https:\/\/doi.org\/10.1186\/s13014-026-02832-x","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board (IRB). All research activities were conducted in accordance with the Declaration of Helsinki and local regulatory requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"168"}}